Annual Meeting on Pharmacology and Therapeutics

November 19, 2018

November 20, 2018

0:00 To 0:00

Yas Island, Abu Dhabi Emirate - Abu Dhabi - United Arab Emirates

https://pharmacology-therapeutics.pulsusconference.com/

$799

800-088-5419

Cardiology CME Conferences Description

About Conference

PULSUS Group takes immense pleasure in inviting all the participants from across the globe to attend “Annual Meeting on Pharmacology and Therapeutics” during April 22-23, 2019 at Dubai, UAE. This comprises of proficient keynote presentations, verbal speeches, productive poster presentations and exhibitions providing insights to the importance and efficiency of Pharma field. The main theme of the conference is “Evincing the Novel Therapeutic Approaches in Pharmacology”

PULSUS Group is an internationally renowned medical peer-review publisher and conferences organizer established in the year 1984 publishes and hosts the work of researchers in a manner that exemplifies the highest standards in research integrity. With a legacy of 30 years of excellence in Medical Publishing, Now, we are running several International Conferences in the fields of Medical, Clinical, Life Science and Pharma.

Pharmacology 2019 focuses on the importance to understand drugs and how they can affect human physiology. It is with better understanding of Pharmacology one can know the right dosage and dosage forms of drugs. More research in pharmacology deals with identifying and responding to drug interactions and its side effects along with its mechanism of action, its therapeutic index and thereby treat accordingly. More intensive study with the interaction between drug and its therapeutic effect helps to identify the properties of ideal drugs.

The Conference provides the research work of pharmacology and therapeutics from various scientific backgrounds and the same can be perceived by pharmacologists, scientists and students. Pharmacology 2019 brings unique platform for scientists, researchers, academicians, professors and students to share their knowledge and views also presenting research about latest pharmacological activities of drugs and chemical properties. PULSUS Group provides an opportunistic environment and vibrant podium through these auspicious events.

Why to attend?

Pharmacology 2019 mainly focusses on the universities, institutes, research centers and major societies along with companies which hold a big market in laboratory technologies. Target audience involves students, faculties, researchers, scientists, dean, directors and CEO’s of the companies.

We welcome all interested participants to join us for our conference on Annual Meeting on Pharmacology and Therapeutics at the exquisite destination Abu Dhabi, UAE.

Our Conference will provide a perfect platform to enlighten knowledge through:

  • Innovative talks by the experts of the global scientific community
  • Sterling workshop and sessions
  • Remarkable Awards and Global Recognition to meritorious Researchers
  • Global Networking with 50+ Countries across the globe
  • Novel Techniques to Benefit Your Research
  • Global Business and Networking Opportunities
  • Exquisite Platform for showcasing your products and International Sponsorship

Scientific Sessions

Track 1: Pharmacology

Pharmacology is the branch of science worried with the investigation of medication action, where a medication can be extensively characterized as any man-made, characteristic, or endogenous (from inside body) atom which applies a biochemical and additionally physiological impact on the cell, tissue, organ, or living being (some of the time the word pharmacon is utilized as a term to envelop these endogenous and exogenous bioactive species). All the more particularly, it is the investigation of the associations that happen between a living life form and chemicals that influence typical or anomalous biochemical capacity. In the event that substances have therapeutic properties, they are considered pharmaceuticals.

Track 2: Cardiovascular Pharmacology

Pharmacology of vascular endothelium deals with alterations of endothelial cells and the vasculature play a central role in the pathogenesis of a broad spectrum of the most dreadful of human diseases, as endothelial cells have the key function of participating in the maintenance of patent and functional capillaries.

Track 3: Clinical Pharmacology and Receptor Theory

Clinical Pharmacology has been practiced for centuries through observing the effects of herbal remedies and early drugs on humans. The pharmacologic effect that a medication has on the body is known as pharmacodynamics. Pharmacokinetic and pharmacodynamics parameters become important because of the association between host drug concentrations, microorganism eradication, and resistance. Since long scientific advances allowed scientists to come together with the study of physiological effects with biological effects Receptor theory for drug effects and its discovery with clinical pharmacology has stretched out to be a multidisciplinary field and has contributed to the findings of drug interaction, therapeutic effectiveness and safety. Drug interactions and pharmacological compatibilities include the study of pharmacokinetics that includes the absorption, distribution, metabolism, and elimination of drugs. The pharmacologic effect that a medication has on the body is known as pharmacodynamics. Pharmacokinetic and pharmacodynamics parameters become especially important because of the association between drug application, microorganism abolition, and resistance.

Track 4: Neuropharmacology and Psychopharmacology

Neuropharmacology is the study of how drugs affect cellular function in the nervous system, and the neural mechanisms through which they influence behavior. There are two main branches of neuropharmacology, behavioral and molecular. Neuropharmacology is the study of how drugs affect cellular function in the nervous system, and the neural mechanisms through which they influence behavior. It is dealt with the interactions of neurotransmitters, neuropeptides, neuro hormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems.

Track 5: Pediatric Pharmacology

Pediatric Pharmacology is in-depth knowledge on the effects of medicines in children came to prominence in recent years due to appreciable increase in publicly funded research and government initiatives towards providing financial incentives to industry. According to NCBI published article an independent analyses of the economic cost and return to industry of the pediatric exclusivity program showed that when research was conducted on nine drugs, the cost to industry ranged from $5 to $44 million, with a median of $12.3 million.

Track 6: Ocular Pharmacology

Ocular Pharmacology deals with basic and clinical research about biopharmaceuticals that have the potential to prevent, treat, and/or diagnose ocular diseases and disorders and its associated treatments. Ophthalmic diseases include those both analogous to systemic diseases and not analogous. Many anterior segment diseases are treated pharmacologically through eye drops, which have an implied therapeutic index of local therapy. Unlike administering pills for systemic diseases, eye drops require patients not only to adhere to treatment, but to be able to accurately perform – i.e., instill drops correctly

Track 7: Immunopharmacology

Immunopharmacology is that area of pharmacological sciences dealing with the selective variation of specific immune responses and, in particular, of immune cell subsets. The first generation of immune-modulating agents included molecules drawn from oncology.  The second generation, notably cyclosporine, exploited some natural agents able to block several signal transduction pathways. To deal with the expanding field of immunopharmacology, some limitations are required. However, in recent years, the advances about how the immune system works have identified several molecular targets suitable for more selective modulation of immune function. These targets can be broadly divided into surface molecules and soluble mediators. Surface molecules play a fundamental role in antigen recognition, immune response activation, homing and effector functions. Soluble mediators are involved in lymphocyte proliferation and differentiation, inflammatory response and cell recruitment.

Track 8: Nursing Pharmacology

Pharmacology for nurses is one of the most important elements in nursing education. It is the field is science that is related to management of drugs as per the disease profile of the patient. The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.

Track 9: Molecular and Cellular Pharmacology

Molecular pharmacology deals with understanding the molecular basis for the actions of drugs and the characteristics of interactions between drug molecules and those of the substrates of drug action in the cell. The methods of molecular pharmacology include precise mathematical, physical, chemical, molecular biological and all biochemical and cell biological techniques to understand how cells respond to hormones or pharmacologic agents, and how chemical structure correlates with biological activity.

Track 10: Pharmacological Testing

Development of medication is a vital concern to medicine. The metabolic stability and the reactivity of a library of candidate drug compounds have to be assessed for drug metabolism and toxicological studies. Many methods of pharmacological tests have been proposed for quantitative predictions in drug metabolism.

Track 11: Ethnopharmacology and Ethnomedicine

Ethnopharmacology is a study or comparison of the traditional medicine practiced by various ethnic groups, and especially by indigenous peoples. The word ethnomedicine is sometimes used as a synonym for traditional medicine. Ethnomedical research is interdisciplinary; in its study of traditional medicines, it applies the methods of ethnobotany and medical anthropology. Often, the medicine traditions it studies are preserved only by oral tradition. Scientific ethnomedical studies constitute either anthropological research or drug discovery research. Anthropological studies examine the cultural perception and context of a traditional medicine. The purpose of drug discovery research is to identify and develop a marketable pharmaceutical product.

Track 12: Pharmacokinetics and Pharmacodynamics

Pharmacokinetics and Pharmacodynamics parameters become important because of the association between host drug concentrations, microorganism eradication, and resistance. The Pharmaceutical industry’s long successful strategy of placing big bets on a few molecules, promoting them heavily and turning them into blockbusters worked well for many years, but its R&D productivity has now plummeted and the environment’s changing. Drug biotransformation reactions. Pharmacokinetics influences decisions over the route of administration. For drugs to produce their effects they must interact with the body. This can happen in many ways and depends on the properties of the drug, and will be discussed later in this chapter. Pharmacokinetics influences decisions over the route of administration. The processes that occur after drug administration can be broken down into four distinct areas (known as ADME) Absorption of the drug, Distribution of the drug molecules, Metabolism of the parent drug and Excretion or elimination of the drug and its metabolites.

Track 13: Advances in Pharmacological Research

Liposomes and nanoparticles: Nanoscale drug delivery systems using liposomes and nanoparticles are rising technologies for the rational delivery of chemotherapeutic drugs in the treatment various ailments. Nanoparticles present possible dangers, both medically and environmentally. The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.

Track 14: Toxicology

Toxicology is the scientific study of adverse effects that occur in living organisms due to chemicals. It involves observing and reporting symptoms, mechanisms, detection and treatments of toxic substances, in particular relation to the poisoning of humans. It includes environmental agents and chemical compounds found in nature, as well as pharmaceutical compounds that are synthesized for medical use by humans. These substances may produce toxic effects in living organisms including disturbance in growth patterns, discomfort, disease and death. LD50 is a common term used in toxicology, which refers to the dose of a substance that displays toxicity in that it kills 50% of a test population. In scientific research, rats or other surrogates are usually used to determine toxicity and the data are extrapolated to use by humans.

Track 15: Pharmacogenetics and Pharmacogenomics

Pharmacogenetics refers to how variation in one single gene influences the response to a single drug and Pharmacogenomics refers to how all of the genes (the genome) can influence responses to drugs. The general feature of these diverse lesions is that two nucleotides on opposite strands are joined covalently. Mutagenicity and carcinogenicity are clearly correlated. Understanding the specificity of mutagens in bacteria has led to the direct implication of certain environmental mutagens in the causation of human cancers Recent advances in DNA repair are DNA inter strand cross-links (ICLs) are lesions caused by a variety of endogenous metabolites, ecological exposures, and cancer chemotherapeutic agents that have two reactive groups. The general feature of these diverse lesions is that two nucleotides on opposite strands are joined covalently. Mutagenicity and carcinogenicity are clearly correlated. The somatic mutation theory of cancer holds that these agents cause cancer by causing the mutation of somatic cells. A unique feature of inter-strand cross-links repair is that both strands of DNA must be incised to completely remove the lesion. Drug dosing guidelines accomplished in sequential steps to prevent creating multiple double-strand breaks. Understanding the specificity of mutagens in bacteria has led to the direct implication of certain environmental mutagens in the causation of human cancers.

Track 16: Pharmacology and Drug Design

Pharmacology is the branch of science worried with the investigation of medication action, where a medication can be extensively characterized as any man-made, characteristic, or endogenous (from inside body) atom which applies a biochemical and additionally physiological impact on the cell, tissue, organ, or living being (some of the time the word pharmacon is utilized as a term to envelop these endogenous and exogenous bioactive species). All the more particularly, it is the investigation of the associations that happen between a living life form and chemicals that influence typical or anomalous biochemical capacity. In the event that substances have therapeutic properties, they are considered pharmaceuticals.

 

Market Analysis

Pharmacology 2019 cordially invites you all to be a part of this conference which is mainly focusing on latest advancements emerging in the field of pharmaceutical sciences. PULSUS Group is providing a great platform for thousands of pharmacists meet, learn, share and exchange views.

According to an international research company, in 2012 the size of the global pharmaceutical market reached $940 billion. In monetary terms it grew by 6%. In the future the sector is expected to grow at no less than 3% to 4% a year and if this happens the market will reach $1.2 trillion in 2016 and up to $1.5 trillion by 2020. Another research company, Business Monitor International, has made a forecast for the size and geographical composition of the global pharmaceutical market in 2020. However by 2020, the Asian pharmaceutical market has a share of 33% in global pharmaceutical market.

Pharmaceutical research work experienced tremendous growth in the past five years. In the next five years growth will increase to 40% as per the market value. Top Companies involved in the Pharmaceutical sales are Pfizer, Johnson & Johnson, Merck, Abbott, etc. from United States.

European countries also play major role in the sales of pharmaceutical products from companies like Novartis, GlaxoSmithKline, Astra Zeneca, French sanofi, Roche, etc.

There is rapid growth in the market and research environment in emerging economies such as Brazil, China and India, leading to a gradual migration of economic and research activities from Europe to these fast-growing markets. In 2012 the Brazilian and Chinese markets grew by 16% and 21% respectively compared to an average market growth of minus 2% for the five major European markets and minus 1% for the US market (source: IMS Retail Drug Monitor – February 2013).

In 2012 North America accounted for 41.0% of world pharmaceutical sales compared with 26.7% for Europe. According to IMS data, 62% of sales of new medicines launched during the period 2007-2011 were on the US market, compared with 18% on the European market.

In 2011 the pharmaceutical industry invested about €29,200 million in R&D in Europe. A decade of strong US market dominance led to a shift of economic and research activity towards the US from 1995-2005. Additionally, Europe is now facing increasing competition from emerging economies: rapid growth in the market and research environments in countries such as Brazil and China are contributing to the move of economic and research activities to non-European markets. The geographical balance of the pharmaceutical market and ultimately the R&D base is likely to shift gradually towards emerging economies.

Importance & Scope:

Thanks to advances in science and technology, the research based pharmaceutical industry is entering an exciting new era in medicines development. According to an international research company, in 2012 the size of the global pharmaceutical market reached $940 billion. In monetary terms it grew by 6%. In the future the sector is expected to grow at no less than 3% to 4% a year and if this happens the market will reach $1.2 trillion in 2016 and up to $1.5 trillion by 2020. Another research company, Business Monitor International, has made a forecast for the size and geographical composition of the global pharmaceutical market in 2020. However by 2020, the Asian pharmaceutical market has a share of 33% in global pharmaceutical market.

Why Abu Dhabi, UAE

The pharmaceutical market in the United Arab Emirates (UAE) is set to grow from just over $3 billion in 2015 to $5.7 billion by 2020, driven by increased healthcare expenditure, mandatory health insurance, and growing medical tourism.

According to research, UAE is quickly gaining popularity as a medical tourism destination due to its low costs, English-speaking medical staff, and virtually non-existent queues for treatment. Indeed, the Dubai Health Authority is working to develop the medical tourism sector, aiming to attract 1.3 million medical tourists annually by 2021. The revenue on medical tourism is expected to grow by 13% annually for the next five years.

Why to attend

Pharmacology 2019 conference will feature 16 technical sessions, poster session, exhibit hall, keynote lectures and special features include workshop/symposium. Pharmacology 2019 is a perfect platform for scientists, decision-makers and students to come together, compare findings, and discuss the science of the future. Share your research with an engaged audience of your peers from around the globe; learn from scientific trail blazers who are designing more sustainable processes; find out how Pharmaceutical innovations are inspiring new businesses and product lines.

Target Audience:

Noble Laureates, Presidents, Vice-Presidents, Directors, Chairs, Co-Chairs, Department Heads, Non-PhD Students, PhD Students, etc. Vendors will have the opportunity to introduce the latest advancements in pharmaceutical sciences to a diverse audience by becoming a conference sponsor via exhibits and/or workshops.

  • Industry       –  20%
  • Student        –  16%
  • Academia    –  44%
  • Government – 12%
  • Others           –  8%

Organizers

Pulsus Group

40 Bloomsbury Way Lower Ground Floor London, United Kingdom WC1A 2SE

44-203-769-1765

//www.pulsus.com

Event Information

5

Contact Information

[email protected]

Visited 597 times, 2 Visits today

Add a Review

Your Rating for this listing:

 

Related Event

Abu Dhabi, UAE

November 26, 2019 To November 27, 2019

10:00 am To 5:00 pm

We are announcing “7th World Congress on Physiotherapy and Rehabilitation” going to be held during November 26-27, 2019 at Abu Dhabi, UAE with the innovative theme “Probing the Advancements and Technologies in Physiotherapy and Rehabilitation”. Read more…

World Cardiology & Cardiologists Congress

dubai, uae

December 3, 2018 To December 4, 2018

55

With great pleasure, Allied academies are honoured to welcome you all with a warm heart to the “WORLD CARDIOLOGY AND CARDIOLOGISTS CONGRESS” which is scheduled on December 3rd and 4th of 2018 in Dubai, UAE. Theme: Re-Inventing the innovative field of Cardiology, For better Tomorrow ORGANIZING COMMITTEE: Prof. Read more…

Cardiovascular, Allergy and Respiratory Summit (CARPS) 2018

Wyndham San Diego Bayside 1355 N Harbor Drive San Diego, California

November 7, 2018 To November 10, 2018

24

Cardiovascular, Allergy and Respiratory Summit (CARPS) is organized by Global Academy for Medical Education and will be held Nov 07 – 10, 2018 at Wyndham San Diego Bayside, San Diego, California, United States of America. Read more…